BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23774550)

  • 1. Autoimmune polyglandular syndrome III in a patient with idiopathic portal hypertension.
    Iwahashi A; Nakatani Y; Hirobata T; Nakata H; Funakoshi S; Yamashita Y; Inoue G
    Intern Med; 2013; 52(12):1375-8. PubMed ID: 23774550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III.
    Wallaschofski H; Meyer A; Tuschy U; Lohmann T
    Horm Metab Res; 2003 Feb; 35(2):120-4. PubMed ID: 12734793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.
    Pulvirenti F; Pentassuglio I; Milito C; Valente M; De Santis A; Conti V; d'Amati G; Riggio O; Quinti I
    J Immunol Res; 2014; 2014():672458. PubMed ID: 24741616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
    Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
    Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic portal hypertension: natural history and long-term outcome.
    Siramolpiwat S; Seijo S; Miquel R; Berzigotti A; Garcia-Criado A; Darnell A; Turon F; Hernandez-Gea V; Bosch J; Garcia-Pagán JC
    Hepatology; 2014 Jun; 59(6):2276-85. PubMed ID: 24155091
    [TBL] [Abstract][Full Text] [Related]  

  • 6.  Idiopathic portal hypertension with multiple hepatic hyperplastic nodules supplied by portal vein.
    Ikeda A; Kita R; Nasu A; Nishijima N; Matsuo H; Kimura T; Osaki Y; Ohbu M
    Ann Hepatol; 2012; 11(4):572-3. PubMed ID: 22700643
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiopathic portal hypertension in a patient with mixed connective tissue disease and protein C deficiency.
    Horai Y; Miyamura T; Hirata A; Nakamura M; Takahama S; Ando H; Minami R; Yamamoto M; Suematsu E
    Intern Med; 2010; 49(18):2013-6. PubMed ID: 20847509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected disappearance of portal cavernoma on long-term anticoagulation.
    Silva-Junior G; Turon F; Hernandez-Gea V; Darnell A; García-Criado Á; García-Pagán JC
    J Hepatol; 2014 Aug; 61(2):446-8. PubMed ID: 24713187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature.
    Kawachi S; Chiba N; Nakagawa M; Kobayashi T; Hikita K; Sano T; Tomita K; Hirano H; Abe Y; Obara H; Shimazu M
    BMC Surg; 2020 Oct; 20(1):257. PubMed ID: 33121468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein receptor 2 in patients with idiopathic portal hypertension.
    De Gottardi A; Seijo S; Milá M; Alvarez MI; Bruguera M; Abraldes JG; Bosch J; García-Pagán JC
    J Cell Mol Med; 2012 Sep; 16(9):2017-21. PubMed ID: 22129439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic portal hypertension complicated by ischemic hepatitis: the diagnostic importance of hemodynamics and liver biopsy.
    Miranda-García P; López-Martín MC; Alvarez-Malé T; Casanova-González MJ; Santander C; Bañares R; Moreno-Otero R; Trapero-Marugán M
    Rev Esp Enferm Dig; 2012 Feb; 104(1):45-7. PubMed ID: 22300122
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies.
    Sato Y; Ren XS; Harada K; Sasaki M; Morikawa H; Shiomi S; Honda M; Kaneko S; Nakanuma Y
    Clin Exp Immunol; 2012 Mar; 167(3):532-42. PubMed ID: 22288597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity.
    Huang W; Connor E; Rosa TD; Muir A; Schatz D; Silverstein J; Crockett S; She JX; Maclaren NK
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2559-63. PubMed ID: 8675578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Screening of Gene Function and Networks by DNA Microarray Analysis in Japanese Patients with Idiopathic Portal Hypertension.
    Kotani K; Kawabe J; Morikawa H; Akahoshi T; Hashizume M; Shiomi S
    Mediators Inflamm; 2015; 2015():349215. PubMed ID: 26549939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Banti's disease. Splenic anemia. Splenomegaly with hepatic cirrhosis].
    PANGARO AJ
    Sem Med; 1961 Jun; 118():1560-75. PubMed ID: 13732442
    [No Abstract]   [Full Text] [Related]  

  • 16. Noncirrhotic Portal Hypertension: Current and Emerging Perspectives.
    Khanna R; Sarin SK
    Clin Liver Dis; 2019 Nov; 23(4):781-807. PubMed ID: 31563222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune polyglandular syndrome type 2 shows the same HLA class II pattern as type 1 diabetes.
    Weinstock C; Matheis N; Barkia S; Haager MC; Janson A; Marković A; Bux J; Kahaly GJ
    Tissue Antigens; 2011 Apr; 77(4):317-24. PubMed ID: 21388354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1/DQB1 susceptibility for autoimmune polyglandular syndrome type II and III in south of Tunisia.
    Fourati H; Mahfoudh N; Abida O; Kammoun A; Mnif F; Haddouk S; Ben Ayed M; Ben Hadj Hmida Y; Rekik N; Abid M; Makni H; Masmoudi H
    Ann Endocrinol (Paris); 2011 Jun; 72(3):232-8. PubMed ID: 21652028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slowly progressive insulin-dependent diabetes in a patient with primary biliary cirrhosis with portal hypertension-type progression.
    Takeshita Y; Takamura T; Inoue O; Okumura M; Kato K; Sunagozaka H; Arai K; Misu H; Nakamura M; Nakanuma Y; Kaneko S
    Intern Med; 2012; 51(1):79-82. PubMed ID: 22214628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction.
    Mori K; Ishimura E; Goto H; Shoji S; Seki S; Yamashita T; Wakasa K; Nishizawa Y; Morii H
    J Gastroenterol; 1996 Feb; 31(1):123-8. PubMed ID: 8808441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.